Northwire Canada EditionSaturday, November 7, 2026
Northwire
⌕
Gold 4,079.60 −0.8% Silver 51.94 −0.8% Copper 6.24 −0.5% Oil 90.83 +0.3% Palladium 1,017.10 −2.6% KRN 0.260 −7.1% GSKR 2.84 +5.6% ADE 0.125 +4.2% NRM 0.055 +0.0% BBB 0.520 −1.9% LGD 2.09 +1.9% DEC 0.110 +0.0% LCE 0.200 +0.0% NILI 0.515 −1.0% CDE 21.85 +6.7% CAN 0.045 +0.0% LORD 0.100 +0.0% HBM 29.49 +2.3% ELEF 0.265 +120.8% MUN 0.300 +0.0% SAGA 0.400 +6.7% Gold 4,079.60 −0.8% Silver 51.94 −0.8% Copper 6.24 −0.5% Oil 90.83 +0.3% Palladium 1,017.10 −2.6% KRN 0.260 −7.1% GSKR 2.84 +5.6% ADE 0.125 +4.2% NRM 0.055 +0.0% BBB 0.520 −1.9% LGD 2.09 +1.9% DEC 0.110 +0.0% LCE 0.200 +0.0% NILI 0.515 −1.0% CDE 21.85 +6.7% CAN 0.045 +0.0% LORD 0.100 +0.0% HBM 29.49 +2.3% ELEF 0.265 +120.8% MUN 0.300 +0.0% SAGA 0.400 +6.7%
Other

Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.

PSYG · Price

Executive Summary

  • Psyence Group Inc. entered into an Amending Agreement with GoldCoast Resource Corp. and its subsidiary to extend key deadlines for the proposed three‑cornered amalgamation.
  • The long‑stop date for required shareholder meetings is now April 30, 2026 (up from Jan 30), and the closing/outside/termination dates are pushed to May 31, 2026 (up from Mar 31).
  • The minimum cash condition at closing was reduced from C$400,000 to C$250,000.

Key Details

  • Amending Agreement Date: February 24, 2026.
  • Parties: Psyence Group Inc., GoldCoast Resource Corp., and Psyence Therapeutics Corp. (wholly‑owned subsidiary).
  • Extended Deadlines:
  • Shareholder meeting long‑stop: Jan 30 → Apr 30, 2026.
  • Closing/Outside date for amalgamation: Mar 31 → May 31, 2026.
  • Termination date under Amalgamation Agreement: Mar 31 → May 31, 2026.
  • Cash Condition Adjustment: Minimum cash at closing lowered from C$400,000 to C$250,000.
  • Purpose of Amendment: Provide additional time to satisfy remaining conditions precedent, including shareholder and regulatory approvals.
  • Trading Status: Shares remain halted pending CSE requirements and completion of the amalgamation.
  • Risk Disclosure: No assurance that the transaction will be completed; subject to CSE “Change of Business” policy and required approvals.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Psyence Group Inc.